Page last updated: 2024-10-26

dimethadione and Diabetes Mellitus, Type 2

dimethadione has been researched along with Diabetes Mellitus, Type 2 in 1 studies

Dimethadione: An anticonvulsant that is the active metabolite of TRIMETHADIONE.

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, W1
Lau, F1
Liu, K1
Wood, HB1
Zhou, G1
Chen, Y1
Li, Y1
Akiyama, TE1
Castriota, G1
Einstein, M1
Wang, C1
McCann, ME1
Doebber, TW1
Wu, M1
Chang, CH1
McNamara, L1
McKeever, B1
Mosley, RT1
Berger, JP1
Meinke, PT1

Other Studies

1 other study available for dimethadione and Diabetes Mellitus, Type 2

ArticleYear
Benzimidazolones: a new class of selective peroxisome proliferator-activated receptor γ (PPARγ) modulators.
    Journal of medicinal chemistry, 2011, Dec-22, Volume: 54, Issue:24

    Topics: Animals; Benzimidazoles; Binding Sites; Chlorocebus aethiops; COS Cells; Crystallography, X-Ray; Dia

2011